Study for persistent COVID symptoms with insulin resistance
Part of Hormones & metabolism, Infections, Lungs & breathing clinical trials.
This trial studies people who have ongoing effects after COVID (often called PASC) and may be related to weight and insulin resistance. It may help researchers find better ways to understand the condition and improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- Your BMI is 25 or higher (a measure related to body weight)
- You are not currently pregnant
- If you are assigned to a biopsy group, you cannot have bleeding risks or certain blood-thinning medicines
- If you are assigned to the healthy control group, you must not have major organ disease, diabetes, or a history of weight-loss surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults over time to understand how weight and body chemistry relate to insulin resistance. It may help researchers learn why insulin resistance happens and what could prevent or improve it.
This study looks at how the body handles insulin in people who are insulin resistant. You will receive a special procedure called a pancreatic clamp to measure insulin sensitivity, which may help researchers understand and treat insulin resistance better.
This study looks at how differences in insulin resistance may change how the liver makes triglycerides (a type of blood fat). It may help researchers understand why some people have higher triglycerides and how to target them better.
This study looks at people with lingering post-COVID symptoms, especially breathing and lung-related findings, using home monitoring and medical tests. It may help researchers understand what’s driving ongoing symptoms and identify patterns that could guide better care.
This study looks at how well the body uses insulin (insulin sensitivity) across different ages, sexes, races, body weights, and whether someone has PCOS. It may help researchers understand why insulin function varies and how PCOS could be linked to metabolic health.
This study uses special PET/CT scans to look at what is happening in your body after COVID-19, to better understand and personalize treatment for ongoing symptoms like fatigue and breathlessness. If you qualify, you'll get advanced imaging that may help your doctors tailor your care.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.